Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvon Protection Regulatory News (AVON)

Share Price Information for Avon Protection (AVON)

Share Price is delayed by 15 minutes
Get Live Data
1,678.00    20.00 (1.21%)
Bid:
1,674.00
Ask:
1,680.00
Spread: 6.00 (0.358%)
Market Cap: £494.20m
AVON Live PriceLast checked at - London Stock Exchange

Intraday Avon Protection Share Chart

Filter Contract Award

20 Dec 2011 09:45

RNS Number : 3098U
Avon Rubber PLC
20 December 2011
 



20 December 2011

FILTER CONTRACT AWARD

Avon is pleased to announce that it has received a 5 year contract from the Department of Defense (DoD) for the supply of spare filters for its M50 respirator. Like previous contracts for spare filters, the contract is an Indefinite Delivery Indefinite Quantity ("IDIQ") contract and has a maximum order quantity of 2.4m filter pairs per year and 12m filter pairs over the contract term. The contract also allows the DoD to extend the term by 2 further option years, potentially extending the duration to 7 years. An initial order has been placed by the DoD with a value of $2.5m for immediate delivery.

This new contract is in addition to the existing sole source $38m, 3 year IDIQ contract announced in August. Avon has also received a further delivery order against this contact with a value of $6.1m for delivery by 1 April 2012.

As expected, the DoD has chosen to dual source the procurement of spare filters and another source has also been selected for a 5 year contract award. The Directors believe that it will take up to 2 years for a comparable product to be developed and approved, after which orders for filters for the M50 mask will be competitively bid. The supply of filters with M50 mask systems will remain sole sourced to Avon.

Commenting on the news, Peter Slabbert, Chief Executive said: "We are delighted to have been awarded this new contract which confirms Avon's position as a supplier of consumable filters to the DoD for a further 5 to 7 years. The procurement of the filter for the M50 mask from another supplier was expected and we believe that our state of the art manufacturing capability, our existing technology advantage and the continuation of the sole source window for up to another 2 years will allow Avon to retain its competitive advantage. We are also committed to widening our capability and product range in the area of filtration to enable us to continue to grow this repeat revenue stream."

For further enquiries, please contact:

Avon Rubber p.l.c.

Peter Slabbert, Chief Executive

01225 896 870

Andrew Lewis, Group Finance Director

01225 896 830

Fiona Stewart, Corporate Communications Executive

01225 896 871

Weber Shandwick Financial

Nick Oborne

020 7067 0700

Stephanie Badjonat

020 7067 0700

 

NOTES TO EDITORS: Avon Rubber p.l.c. is a world leader in the design, test and manufacture of advanced Chemical, Biological, Radiological and Nuclear (CBRN) respiratory protection solutions to the worlds military, law enforcement, first responder, emergency services, fire and industrial markets. Avon has a unique capability in CBRN protection based on a range of advanced CBRN technologies in respirator design, filtration and compressed air breathing apparatus. This enables Avon to develop specialised solutions that take full account of user requirements. Avon also owns a world leading dairy business manufacturing liners and tubing for the automated milking process. For further information please visit the Group's website www.avon-rubber.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTGCBDDRDDBGBG
Date   Source Headline
21st Mar 20194:00 pmRNSDirector/PDMR Shareholding
14th Mar 20192:01 pmRNSHolding(s) in Company
6th Mar 20194:00 pmRNSDirector/PDMR Shareholding
21st Feb 201912:00 pmRNSHolding(s) in Company
8th Feb 20197:00 amRNSDirector/PDMR Shareholding
1st Feb 201910:00 amRNSResult of AGM
1st Feb 20197:00 amRNSU.S. Department of Defense M69 Aircrew Mask Orders
31st Jan 20197:00 amRNSAnnual General Meeting - Trading Update
9th Jan 20194:00 pmRNSDirector/PDMR Shareholding
7th Jan 20197:00 amRNSUS Department of Defense M69 Aircrew Mask Contract
11th Dec 201812:00 pmRNSDirector/PDMR Shareholding
5th Dec 20184:00 pmRNSDirector/PDMR Shareholding
4th Dec 20183:00 pmRNSDirector/PDMR Shareholding
30th Nov 201812:00 pmRNSNotice of Annual Report and Accounts and AGM
14th Nov 20184:26 pmRNSDirector/PDMR Shareholding
14th Nov 20187:00 amRNSFinal Results
5th Nov 20183:48 pmRNSDirector/PDMR Shareholding
5th Oct 20184:06 pmRNSDirector/PDMR Shareholding
17th Sep 20183:07 pmRNSDirector/PDMR Shareholding
14th Sep 20187:00 amRNSPre-close trading update
6th Sep 201811:33 amRNSDirector/PDMR Shareholding
8th Aug 201810:26 amRNSDirector/PDMR Shareholding
26th Jul 20184:29 pmRNSDirector/PDMR Shareholding
26th Jul 20182:59 pmRNSDirector/PDMR Shareholding
17th Jul 20187:30 amRNSUS DoD M50 Mask Systems Order
6th Jul 20189:24 amRNSDirector/PDMR Shareholding
8th Jun 20189:24 amRNSHolding(s) in Company
5th Jun 20183:01 pmRNSDirector/PDMR Shareholding
30th May 20182:55 pmRNSDirector/PDMR Shareholding
18th May 201812:11 pmRNSDirector/PDMR Shareholding
16th May 20182:57 pmRNSDirector/PDMR Shareholding
8th May 20183:45 pmRNSDirector/PDMR Shareholding
2nd May 20187:00 amRNSHalf-year Report
6th Apr 20189:54 amRNSDirector/PDMR Shareholding
3rd Apr 20187:00 amRNSDisposal
13th Mar 20187:00 amRNSCapital Markets Event
5th Mar 20184:19 pmRNSDirector/PDMR Shareholding
23rd Feb 20184:17 pmRNSDirector/PDMR Shareholding
15th Feb 20185:43 pmRNSHolding(s) in Company
15th Feb 20187:00 amRNSUK MoD General Service Respirator Agreement
14th Feb 20185:13 pmRNSHolding(s) in Company
7th Feb 20185:30 pmRNSHolding(s) in Company
5th Feb 20184:13 pmRNSDirector/PDMR Shareholding
1st Feb 20183:58 pmRNSResult of AGM
1st Feb 20187:00 amRNSAGM Statement
29th Jan 20187:00 amRNSUS Department of Defense Mask Systems Order
24th Jan 20185:38 pmRNSHolding(s) in Company
24th Jan 201811:44 amRNSHolding(s) in Company
9th Jan 20188:52 amRNSDirector/PDMR Shareholding
20th Dec 201712:16 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.